Lionsgate Studios initiated with an Overweight at Morgan Stanley

Morgan Stanley initiated coverage of Lionsgate Studios with an Overweight rating and $9.50 price target. The company is expected to deliver 8% proforma adjusted OIBDA growth annually through fiscal 2028 through a differentiated film strategy and continued healthy global demand for content, the analyst tells investors in a research note. The firm says concerns over spending rationalization among content buyers is priced into Lionsgate Studios shares, which are trading below historical levels and comps.